Melatonin Enhances Cancer Chemotherapy Efficacy
Author Information
Author(s): Messina Giuseppina, Lissoni Paolo, Marchiori Paolo, Bartolacelli Erio, Brivio Fernando, Magotti Luciano
Primary Institution: Fondazione IRCCS, Ospedale Maggiore Policlinico, Milan, Italy
Hypothesis
The study evaluates the efficacy of melatonin in enhancing cancer chemotherapy and its relation to the psychospiritual status of cancer patients.
Conclusion
Melatonin may enhance the efficacy of chemotherapy, particularly in patients with spiritual faith.
Supporting Evidence
- Patients treated with chemotherapy plus melatonin had a higher tumor response rate than those treated with chemotherapy alone.
- The best results were seen in patients with spiritual faith.
- 42% of patients treated with chemotherapy plus melatonin achieved tumor regression.
Takeaway
Melatonin, a hormone, can help make cancer treatments work better, especially for patients who believe in something spiritual.
Methodology
The study involved 50 metastatic NSCLC patients treated with chemotherapy and melatonin, compared to a control group of 100 patients treated with chemotherapy alone.
Potential Biases
The psychospiritual status of patients may influence the results.
Limitations
The small sample size limits the ability to draw definitive conclusions.
Participant Demographics
35 males and 15 females with metastatic non-small cell lung cancer.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Want to read the original?
Access the complete publication on the publisher's website